Home
Library
Search
History
Settings
Plans
Log in
Create account
Home
Library
Search
History
Settings
Plans
Log in
Create account
The belated US FDA approval of the adenosine A2A receptor antagonist istradefylline for treatment of Parkinson’s disease
Authors:
Jiang‐Fan Chen
,
Rodrigo A. Cunha
-
Purinergic Signalling
2020
cited by 227
✨
Checking sign-in…
PDF
Cited by
View BibTeX
Hide BibTeX
View BibTeX
Cite
The belated US FDA approval of the adenosine A2A receptor antagonist istradefylline for treatment of Parkinson’s disease | Litlas